Mesoblast (MESO) Short Interest Ratio & Short Volume $12.10 +0.34 (+2.89%) (As of 12/16/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Mesoblast Short Interest DataMesoblast (MESO) has a short interest of 1.42 million shares. This marks a -15.48% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.1, indicating that it would take 7.1 days of the average trading volume of 724,615 shares to cover all short positions.Current Short Interest1,420,000 sharesPrevious Short Interest1,680,000 sharesChange Vs. Previous Month-15.48%Dollar Volume Sold Short$16.60 millionShort Interest Ratio7.1 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares114,178,000 sharesPercentage of Shares Shorted1.24%Today's Trading Volume338,290 sharesAverage Trading Volume724,615 sharesToday's Volume Vs. Average47% Short Selling Mesoblast? Sign up to receive the latest short interest report for Mesoblast and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMESO Short Interest Over TimeMESO Days to Cover Over TimeMESO Percentage of Float Shorted Over Time Ad Brownstone ResearchMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.So please click here to see the details because a lot of people could get rich. Mesoblast Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20241,420,000 shares $16.60 million -15.5%N/A7.1 $11.69 11/15/20241,680,000 shares $16.87 million +20.9%N/A9 $10.04 10/31/20241,390,000 shares $11.65 million +11.2%N/A9.1 $8.38 10/15/20241,250,000 shares $12.03 million +34.3%N/A7.9 $9.62 9/30/2024931,100 shares $7.61 million -7.8%N/A5.3 $8.17 9/15/20241,010,000 shares $6.28 million +20.5%N/A6.4 $6.22 Get the Latest News and Ratings for MESO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mesoblast and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024838,200 shares $5.65 million +9.1%N/A5.3 $6.74 8/15/2024768,300 shares $4.92 million +15.7%N/A4.5 $6.40 7/31/2024663,800 shares $4.49 million +77.8%N/A3.5 $6.77 7/15/2024373,300 shares $2.86 million -18.9%N/A1.7 $7.65 6/30/2024460,500 shares $3.14 million -2.2%N/A1.8 $6.81 6/15/2024470,900 shares $3.43 million -6.0%N/A0.2 $7.28 5/31/2024500,800 shares $3.73 million -36.0%N/A0.2 $7.44 5/15/2024781,900 shares $5.63 million -12.8%N/A0.4 $7.20 4/30/2024896,400 shares $5.92 million +25.2%N/A0.4 $6.60 4/15/2024716,100 shares $3.70 million -69.4%N/A0.3 $5.17 3/31/20242,340,000 shares $11.72 million +190.1%N/A1.1 $5.01 3/15/2024806,500 shares $1.96 million +59.2%N/A0.5 $2.43 2/29/2024506,600 shares $995,469.00 -6.8%N/A1.2 $1.97 2/15/2024543,500 shares $1.10 million -9.7%N/A2.7 $2.03 1/31/2024601,900 shares $1.06 million +23.0%N/A3.2 $1.76 1/15/2024489,400 shares $954,330.00 -22.8%N/A2.5 $1.95 12/31/2023633,600 shares $1.39 million -17.8%N/A4.2 $2.20 12/15/2023771,200 shares $825,184.00 +16.4%N/A2.7 $1.07 11/30/2023662,600 shares $901,136.00 -9.7%N/A4.6 $1.36 11/15/2023734,100 shares $946,989.00 +5.1%N/A5.1 $1.29 10/31/2023698,600 shares $852,292.00 +2.3%N/A2.6 $1.22 10/15/2023683,200 shares $840,336.00 -22.0%N/A1.5 $1.23 9/30/2023876,300 shares $1.08 million -6.9%N/A1.7 $1.23 9/15/2023941,200 shares $1.34 million -15.2%N/A1.8 $1.42 8/31/20231,110,000 shares $1.79 million -51.5%N/A2.1 $1.61 8/15/20232,290,000 shares $2.91 million +76.2%N/A4.6 $1.27 7/31/20231,300,000 shares $5.20 million +107.4%N/A3.3 $4.00 7/15/2023626,800 shares $3.01 million +52.1%N/A3.2 $4.80 6/30/2023412,000 shares $1.61 million -9.8%N/A2.9 $3.91 6/15/2023456,600 shares $1.68 million +5.9%N/A3.8 $3.68 5/31/2023431,100 shares $1.46 million -6.0%N/A3.7 $3.38 5/15/2023458,400 shares $1.70 million -14.8%N/A3.7 $3.70 4/30/2023537,900 shares $1.59 million +29.0%N/A3.7 $2.95 4/15/2023416,900 shares $1.43 million +13.4%N/A3.1 $3.44AI breakthrough about to upend industry (Ad)Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.I urge you to watch it now. 3/31/2023367,500 shares $1.21 million +7.8%N/A2.5 $3.29 3/15/2023341,000 shares $1.06 million -54.2%N/A2.3 $3.12 2/28/2023745,100 shares $2.46 million +12.9%N/A4.5 $3.30 2/15/2023659,900 shares $2.29 million +45.3%N/A4.5 $3.47 1/31/2023454,200 shares $1.50 million +7.5%N/A3.3 $3.30 1/15/2023422,700 shares $1.39 million +2.5%N/A3.7 $3.28 12/30/2022412,400 shares $1.20 million -27.6%N/A3.8 $2.91 12/15/2022569,800 shares $1.78 million +10.9%N/A5.7 $3.13 11/30/2022513,700 shares $1.90 million -2.1%N/A6.5 $3.70 11/15/2022524,800 shares $1.72 million -2.6%N/A8 $3.27 10/31/2022538,600 shares $1.57 million -4.2%N/A8.7 $2.91 10/15/2022561,900 shares $1.75 million +8.9%N/A8.4 $3.11 9/30/2022516,000 shares $1.31 million +3.5%N/A7.4 $2.55 9/15/2022498,800 shares $1.59 million -0.6%N/A6.9 $3.19 8/31/2022501,700 shares $1.49 million +2.0%N/A6.7 $2.96 8/15/2022491,900 shares $1.56 million +0.2%N/A6.6 $3.17 7/31/2022490,700 shares $1.64 million -4.8%N/A6.4 $3.34 7/15/2022515,600 shares $1.49 million -13.6%N/A7.3 $2.89 6/30/2022596,400 shares $1.32 million -7.2%N/A8.4 $2.22 6/15/2022642,300 shares $1.52 million -0.1%N/A9.3 $2.37 5/31/2022643,000 shares $2.26 million -26.1%N/A8.8 $3.51 5/15/2022869,500 shares $3.07 million -5.2%N/A11.9 $3.53 4/30/2022917,500 shares $3.37 million -11.8%N/A13.3 $3.67 4/15/20221,040,000 shares $4.47 million -2.8%N/A13.8 $4.30 3/31/20221,070,000 shares $4.52 million -7.0%N/A14.2 $4.22 3/15/20221,150,000 shares $5.03 million -0.9%N/A11.5 $4.37 2/28/20221,160,000 shares $4.51 million -2.5%N/A6.2 $3.89 2/15/20221,190,000 shares $4.84 million -0.8%N/A5.9 $4.07 1/31/20221,200,000 shares $4.85 million +2.6%N/A5.5 $4.04 1/15/20221,170,000 shares $5.42 million +2.6%N/A5.3 $4.63 12/31/20211,140,000 shares $5.47 million +1.8%N/A5.1 $4.80 12/15/20211,120,000 shares $5.57 million -8.2%N/A5.2 $4.97 11/30/20211,220,000 shares $7.38 million +1.7%N/A8.1 $6.05 11/15/20211,200,000 shares $8.51 million -1.6%N/A7.9 $7.09 10/29/20211,220,000 shares $7.38 million +9.9%N/A9 $6.05 10/15/20211,110,000 shares $6.30 million -10.5%N/A8.4 $5.68 9/30/20211,240,000 shares $7.45 million No ChangeN/A9.7 $6.01 9/15/20211,240,000 shares $7.87 million -23.9%N/A9.5 $6.35 8/31/20211,630,000 shares $10.64 million +5.8%N/A10.6 $6.53 8/13/20211,540,000 shares $11.58 million No ChangeN/A11.9 $7.52 7/30/20211,540,000 shares $10.78 million +4.8%N/A10.9 $7.00 7/15/20211,470,000 shares $10.88 million +2.8%N/A6.7 $7.40 6/30/20211,430,000 shares $10.70 million +8.3%N/A6.4 $7.48 6/15/20211,320,000 shares $10.86 million -0.8%N/A5.6 $8.23 5/28/20211,330,000 shares $10.28 million -2.2%N/A6.1 $7.73 5/14/20211,360,000 shares $9.15 million -2.9%N/A5.8 $6.73 4/30/20211,400,000 shares $10.11 million +6.1%N/A4.5 $7.22 4/15/20211,320,000 shares $11.48 million +10.0%N/A4.8 $8.70 3/31/20211,200,000 shares $9.91 million -18.9%N/A2 $8.26 3/15/20211,480,000 shares $13.81 million -21.3%N/A2 $9.33AI breakthrough about to upend industry (Ad)Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.I urge you to watch it now. 2/26/20211,880,000 shares $18.05 million -33.3%N/A2.5 $9.60 2/12/20212,820,000 shares $30.88 million -10.2%N/A3.4 $10.95 1/29/20213,140,000 shares $28.92 million -15.8%N/A4 $9.21 1/15/20213,730,000 shares $36.67 million +11.0%N/A4.8 $9.83 12/31/20203,360,000 shares $28.66 million +8.0%N/A4.4 $8.53 12/15/20203,110,000 shares $52.53 million -0.3%N/A5 $16.89 11/30/20203,120,000 shares $46.58 million -4.9%N/A5.7 $14.93 11/15/20203,280,000 shares $38.97 million +0.9%N/A5.2 $11.88 10/30/20203,250,000 shares $35.43 million +8.7%N/A3 $10.90 10/15/20202,990,000 shares $35.46 million -4.8%N/A2.5 $11.86 9/30/20203,140,000 shares $58.36 million +18.1%N/A2.7 $18.59 9/15/20202,660,000 shares $47.08 million +21.5%N/A2.5 $17.70 8/31/20202,190,000 shares $42.40 million +7.9%N/A2.1 $19.36 8/14/20202,030,000 shares $36.30 million +25.3%N/A2 $17.88 7/31/20201,620,000 shares $21.74 million +14.1%N/A2.9 $13.42 7/15/20201,420,000 shares $16.26 million +19.3%N/A1.3 $11.45 6/30/20201,190,000 shares $12.98 million +26.8%N/A1 $10.91 6/15/2020938,400 shares $11.53 million +11.9%N/A0.8 $12.29 5/29/2020838,700 shares $10.61 million -28.3%N/A0.7 $12.65 5/15/20201,170,000 shares $14.39 million +10.4%N/A1.1 $12.30 4/30/20201,060,000 shares $11.63 million +76.6%N/A1.1 $10.98 4/15/2020600,400 shares $4.42 million +158.6%N/A0.8 $7.36 3/31/2020232,200 shares $3.59 million +46.4%N/A1.2 $15.45 3/13/2020158,600 shares $1.10 million -16.1%N/A1 $6.96 2/28/2020189,000 shares $638,820.00 -41.0%N/A2.2 $3.38 2/14/2020320,500 shares $2.39 million +8.6%N/A4.4 $7.45 1/31/2020295,000 shares $2.43 million +7.8%N/A4.6 $8.24 1/15/2020273,700 shares $2.60 million -2.1%N/A5.1 $9.51 12/31/2019279,500 shares $2.97 million +0.7%N/A8 $10.63 MESO Short Interest - Frequently Asked Questions What is Mesoblast's current short interest? Short interest is the volume of Mesoblast shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 1,420,000 shares of MESO short. Learn More on Mesoblast's current short interest. What is a good short interest ratio for Mesoblast? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MESO shares currently have a short interest ratio of 7.0. Learn More on Mesoblast's short interest ratio. Which institutional investors are shorting Mesoblast? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Mesoblast: Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Mesoblast's short interest increasing or decreasing? Mesoblast saw a decline in short interest in November. As of November 30th, there was short interest totaling 1,420,000 shares, a decline of 15.5% from the previous total of 1,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mesoblast's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Mesoblast: ADMA Biologics, Inc. (5.46%), Ultragenyx Pharmaceutical Inc. (3.66%), Arcellx, Inc. (12.85%), Apellis Pharmaceuticals, Inc. (17.53%), Biohaven Ltd. (7.75%), Avidity Biosciences, Inc. (12.52%), Immunovant, Inc. (20.39%), Scholar Rock Holding Co. (15.76%), Organon & Co. (5.32%), PTC Therapeutics, Inc. (5.96%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Mesoblast stock? Short selling MESO is an investing strategy that aims to generate trading profit from Mesoblast as its price is falling. MESO shares are trading up $0.34 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mesoblast? A short squeeze for Mesoblast occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MESO, which in turn drives the price of the stock up even further. How often is Mesoblast's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MESO, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies ADMA Short Interest RARE Short Interest ACLX Short Interest APLS Short Interest BHVN Short Interest RNA Short Interest IMVT Short Interest SRRK Short Interest OGN Short Interest PTCT Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MESO) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MESO Stock Alerts